Analyst Group Comment on ODI Pharma’s Strategic Market Entry to Switzerland

ODI Pharma announced on June 25th that the company has completed a first delivery of products to the Swiss market, a new market for ODI Pharma. The delivery will be made to the leading medical cannabis provider in Switzerland and will be facilitated through ODI Pharma’s Swiss subsidiary.

Länk till analysen i sin helhet: https://analystgroup.se/kommentarer/comment-on-odi-pharmas-strategic-market-entry-to-switzerland/